The activation of human blood coagulation factor X on the surface of endothelial cells: A comparison with various vascular cells, platelets and monocytes

British Journal of Haematology

Volumn 87, Issue 2, 1994, Pages 332-342

  Brinkman, H J M ^a   Mertens, K ^a   Holthuis, J ^a   Zwart Huinink, L A ^a   Grijm, K ^a   Van Mourik, J A ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

Coagulation; Endothelial cells; Factor VIII; Monocytes; Vessel wall

Indexed keywords

BLOOD CLOTTING FACTOR 10; CALCIMYCIN; LIPOPOLYSACCHARIDE; PHORBOL ESTER; PROTHROMBIN FRAGMENT 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BLOOD VESSEL WALL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0028241067     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1994.tb04918.x     Document Type: Article

References (40)

1. Ahsmann, E.J.M., Lokhourst, H.M., Dekker, A.W. & Bloem, A.C. (1992) Lymphocyte function‐associated antigen‐1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood, 79, 2068–2075.
2. Bakkus, M.H.C., Brakel‐van Peer, K.M.J., Adriaansen, H.J., Van Den Akker, T.W. & Benner, R. (1991) Detection of interleukin‐1β and interleukin‐6 expression in human multiple myeloma by fluorescent in situ hybridization. Leukemia and Lymphoma, 4, 389–395.
3. Barker, H.F., Hamilton, M.S., Ball, J., Drew, M. & Franklin, I.M. (1992) Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells. British Journal of Haematology, 81, 331–335.
4. Bataille, R., Jourdan, M., Zhang, X.‐G. & Klein, B. (1989) Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation, 84, 2008–2011.
5. Becker, Y., Asher, Y. & Tabor, E. (1992) Transfection of SV40‐transformed ataxia‐telangiectasia fibroblasts with mouse DNA corrects hypersensitivity to neocarzinostatin and activates fibronectin gene expression. Israel Journal of Medical Sciences, 28, 837–847.
6. Berenson, J., Wong, R., Kim, K., Brown, N. & Lichtenstein, A. (1987) Evidence for peripheral blood B lymphocytes but not T lymphocyte involvement in multiple myeloma. Blood, 70, 1550–1553.
7. Burk, K.H., Drewinko, B., Trujillo, J.M. & Aheran, M.J. (1978) Establishment of a human plasma cell line in vitro. Cancer Research, 38, 2508–2513.
8. Caligaris‐Cappio, F., Bergui, L., Gaidano, G.L., Mercio, F. & Schena, M. (1991) In vitro studies provide evidence that multiple paracrine loops may be operating in multiple myeloma. Epidemiology and Biology of Multiple Myeloma (ed. by G. I. Obrams and M. Potter), pp. 123–127.
9. Diehl, V., Schaadt, M., Kirchner, H., Hellriegel, K.P., Gudat, F., Fonatasch, C., Laskewitz, E. & Guggenheim, R. (1978) Long‐term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. Blut, 36, 331–338.
10. Durie, B.G.M., Grogan, T.M., Spier, C., Vela, E., Baum, V., Rodriguez, M.A. & Frutiger, Y. (1989) Myelomonocytic myeloma cell line (LB84‐1). Blood, 73, 770–776.
11. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842–854.
12. Eton, O., Scheinberg, D.A. & Houghton, A.N. (1989) Establishment and characterization of two human myeloma cell lines secreting kappa light chains. Leukemia, 3, 729–735.
13. Garcia‐Pardo, A., Wayner, E.A., Carter, W.G. & Ferreira, O.C. (1990) Human B lymphocytes define an alternative mechanism of adhesion of fibronectin. The interaction of the α4β1 integrin with the LHGPEILDVPST sequence of the type III connecting segment is sufficient to promote cell attachment. Journal of Immunology, 144, 3361–3366.
14. Geerts, A., Greenwel, B., Cunningham, M., De Pleser, P., Rogiers, V., Wisse, E. & Rojkind, M. (1993) Identification of connective tissue gene transcripts in freshly isolated parenchymal, endothelial, Kupffer and fat‐storing cells by Northern hybridization analysis. Journal of Hepatology, 19, 148–158.
15. Gordon, M.Y. & Greaves, M.F. (1989) Physiological mechanisms of stem cell regulation in bone marrow transplantation and haemopoiesis. Bone Marrow Transplantation, 4, 335–338.
16. Grogan, T.M., Durie, B.M.G., Lomen, C., Spies, C., Wirt, D.P., Nagle, R., Wilson, G.S., Richter, L., Vela, E., Maxey, V., McDaniel, K. & Rangel, C. (1987) Delineation of a novel pre‐B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture and kinetic features. Blood, 70, 932–942.
17. Hamilton, M.S., Ball, J., Bromidge, E. & Franklin, I.M. (1991) Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. British Journal of Haematology, 78, 60–65.
18. Hamilton, M.S., Ball, J., Bromidge, E., Lowe, J. & Franklin, I.M. (1990) Characterization of a new IgGl myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma. British Journal of Haematology, 75, 378–384.
19. Hershkoviz, R., Alon, R., Gilat, D. & Lider, O. (1992) Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion. Cellular Immunology, 141, 352–361.
20. Jackson, N., Lowe, J., Ball, J., Bromidge, E., Ling, N.R., Larkins, S., Griffith, M.J. & Franklin, I.M. (1989) Two new IgAl‐ k plasma cell leukaemia cell lines (JJN‐1 and JJN‐2) which proliferate in response to B cell stimulatory factor 2. Clinical and Experimental Immunology, 75, 93–99.
21. Jernberg‐Wiklund, H., Petterson, M., Carlsson, M. & Nilsson, K. (1992) Increase in interleukin 6 (IL‐6) and IL‐6‐receptor expression in a human multiple myeloma cell line, U‐266, during long‐term in vitro culture and the development of a possible autocrine IL‐6 loop. Leukemia, 6, 310–318.
22. Katagiri, S., Yonezawa, T., Kuyama, J., Kanayama, Y., Nishida, K., Abe, T., Tamali, T., Ohnishi, M. & Tauri, S. (1985) Two distinct human myeloma cell lines originating from one patient with myeloma. International Journal of Cancer, 36, 241–246.
23. Klein, B. & Bataille, R. (1992) Cytokine network in human multiple myeloma. Hematology/Oncology Clinics of North America, 6, 273–284.
24. Kornblitt, A.R., Umezawa, K., Vibe‐Pedersen, K. & Baralle, F.E. (1985) Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. European Molecular Biology Organization Journal, 4, 1755.
25. Nakamura, M., Merchav, S., Carter, A., Ernst, T.J., Demetri, G.D., Furukawa, Y., Anderson, K., Freedman, A.S. & Griffin, J.D. (1989) Expression of a novel 3.5 kb macrophage colony‐stimulating factor transcript in human myeloma cells. Journal of Immunology, 143, 3543–3547.
26. Nillson, K. (1971) Characteristics of established myeloma and lymphoblastoid cell lines derived from an IgE myeloma patient: a comparative study. International Journal of Cancer, 7, 380–396.
27. Odermatt, E., Tamkun, J.W. & Hynes, R.O. (1985) Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation. Proceedings of the National Academy of Sciences of the United States of America, 82, 6571–6573.
28. Paizi, M., Manaster, J., Quitt, M. & Spira, G. (1991) High plasma fibronectin levels in multiple myeloma patients: possible mechanisms and clinical implications. Scandinavian Journal of Immunology, 34, 285–289.
29. Pegoraro, L., Malavasi, F., Bellone, G., Massaia, M., Boccadoro, M., Saglio, G., Guerrasio, A., Benetton, G. Lombardi, L., Coda, R. & Avanzi, G.C. (1989) The human myeloma cell line LP‐1: a versatile model in which to study early plasma cell differentiation and c‐myc activation. Blood, 73, 1020–1027.
30. Ridley, R.C., Xiao, H., Hata, H., Woodliff, J., Epstein, J. & Sanderson, R.D. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood, 81, 767–774.
31. Roldan, E., Garcia‐Pardo, A. & Brieva, J.A. (1992) VLA‐4‐fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion. Journal of Experimental Medicine, 175, 1739–1747.
32. Ruoslahti, E. (1988) Fibronectin and its receptors. Annual Review of Biochemistry, 57, 375–413.
33. Schwarzbauer, J., Tamkun, J., Lemischka, I. & Hynes, R. (1983) Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell, 35, 421–431.
34. Shimizu, S., Yoshioka, R., Hirose, Y., Sugai, S., Tachibana, J. & Konda, S. (1989) Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon β2)‐dependent human bone marrow‐derived myeloma cell lines. Journal of Experimental Medicine, 169, 339–344.
35. Van Camp, B., Durie, B.G.M., Spier, C., De Waele, M., Van Riet, I., Vela, E., Frutiger, Y., Richter, L. & Grogan, T.M. (1990) Plasma cells in multiple myeloma express a natural killer cell‐associated antigen: CD56 (NKH‐1; Leu‐19). Blood, 76, 377–382.
36. Van Riet, I., De Waele, M., Remels, L., Lacor, P. Schots, R. & Van Camp, B. (1991) Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. British Journal of Haematology, 79, 421–427.
37. Van Riet, I., Heirman, C., Lacor, P., De Waele, M., Thielemans, K. & Van Camp, B. (1989) Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangements studies. British Journal of Haematology, 73, 289–295.
38. Zerlauch, G. & Wolf, G. (1984) Plasma fibronectin as a marker for cancer and other diseases. American Journal of Medicine, 77, 685–689.
39. Zhang, X.G., Bataille,. R., Jourdan, M., Sealand, S., Banchereau, J., Mannoni, P. & Klein, B. (1990) GM‐CSF synergizes with interleukin 6 in supporting the proliferation of human myeloma cells. Blood, 76, 2599–2605.
40. Zhang, X.G., Klein, B. & Bataille, R. (1989) Interleukin 6 is a potent myeloma‐cell growth factor in patients with aggressive multiple myeloma. Blood, 74, 11–13.